All-Ericsson C - Search Results

1

Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma.

Mougiakakos D, Johansson CC, Trocme E, All-Ericsson C, Economou MA, Larsson O, Seregard S, Kiessling R. Mougiakakos D, et al. Cancer. 2010 May 1;116(9):2224-33. doi: 10.1002/cncr.24999. Cancer. 2010. PMID: 20209608 Free article.

2

Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.

Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O, Seregard S. Economou MA, et al. Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4372-5. doi: 10.1167/iovs.05-0322. Invest Ophthalmol Vis Sci. 2005. PMID: 16303922

3

The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.

Girnita A, All-Ericsson C, Economou MA, Aström K, Axelson M, Seregard S, Larsson O, Girnita L. Girnita A, et al. Clin Cancer Res. 2006 Feb 15;12(4):1383-91. doi: 10.1158/1078-0432.CCR-05-1106. Clin Cancer Res. 2006. PMID: 16489097

4

Expression and prognostic significance of iNOS in uveal melanoma.

Johansson CC, Mougiakakos D, Trocme E, All-Ericsson C, Economou MA, Larsson O, Seregard S, Kiessling R. Johansson CC, et al. Int J Cancer. 2010 Jun 1;126(11):2682-9. doi: 10.1002/ijc.24984. Int J Cancer. 2010. PMID: 19847812

5

Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.

Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O, Seregard S. Economou MA, et al. Acta Ophthalmol. 2008 Nov;86 Thesis 4:20-5. doi: 10.1111/j.1755-3768.2008.01182.x. Acta Ophthalmol. 2008. PMID: 19032678 Free article.

6

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. All-Ericsson C, et al. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8. Invest Ophthalmol Vis Sci. 2002. PMID: 11773005

7

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

All-Ericsson C, Girnita L, Müller-Brunotte A, Brodin B, Seregard S, Ostman A, Larsson O. All-Ericsson C, et al. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2075-82. doi: 10.1167/iovs.03-1196. Invest Ophthalmol Vis Sci. 2004. PMID: 15223779

8

Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.

Economou MA, Andersson S, Vasilcanu D, All-Ericsson C, Menu E, Girnita A, Girnita L, Axelson M, Seregard S, Larsson O. Economou MA, et al. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2337-42. doi: 10.1167/iovs.07-0819. Invest Ophthalmol Vis Sci. 2008. PMID: 18515579

9

The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.

Girnita A, All-Ericsson C, Economou MA, Aström K, Axelson M, Seregard S, Larsson O, Girnita L. Girnita A, et al. Acta Ophthalmol. 2008 Nov;86 Thesis 4:26-34. doi: 10.1111/j.1755-3768.2008.01183.x. Acta Ophthalmol. 2008. PMID: 19032679 Free article.

10

Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.

Economou MA, Andersson S, Vasilcanu D, All-Ericsson C, Menu E, Girnita A, Girnita L, Axelson M, Seregard S, Larsson O. Economou MA, et al. Acta Ophthalmol. 2008 Nov;86 Thesis 4:35-41. doi: 10.1111/j.1755-3768.2008.01184.x. Acta Ophthalmol. 2008. PMID: 19032680 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters